Novo Nordisk shares plunge to four-year low after Alzheimer's drug trial fails to hit key target

Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal.

# Novo Nordisk shares plunge to four-year low after Alzheimer's drug trial fails to hit key target Shares of Novo Nordisk plunged after the Danish drug pharmaceutical company said a highly-anticipated trial for Alzheimer's disease failed to meet its main goal. **Read the full article:** [CNBC](https://www.cnbc.com/2025/11/24/novo-nordisk-shares-plunge-after-alzheimers-drug-trial-fails-to-hit-key-target.html) *This article was originally published by CNBC. MoneyWiseInc provides expert curation of the best financial content from trusted sources.*